Gupta, M.; Anjari, M.; Brandner, S.; Fersht, N.; Wilson, E.; Thust, S.; Kosmin, M.
Isocitrate Dehydrogenase 1/2 Wildtype Adult Astrocytoma with WHO Grade 2/3 Histological Features: Molecular Re-Classification, Prognostic Factors, Clinical Outcomes. Biomedicines 2024, 12, 901.
https://doi.org/10.3390/biomedicines12040901
AMA Style
Gupta M, Anjari M, Brandner S, Fersht N, Wilson E, Thust S, Kosmin M.
Isocitrate Dehydrogenase 1/2 Wildtype Adult Astrocytoma with WHO Grade 2/3 Histological Features: Molecular Re-Classification, Prognostic Factors, Clinical Outcomes. Biomedicines. 2024; 12(4):901.
https://doi.org/10.3390/biomedicines12040901
Chicago/Turabian Style
Gupta, Meetakshi, Mustafa Anjari, Sebastian Brandner, Naomi Fersht, Elena Wilson, Steffi Thust, and Michael Kosmin.
2024. "Isocitrate Dehydrogenase 1/2 Wildtype Adult Astrocytoma with WHO Grade 2/3 Histological Features: Molecular Re-Classification, Prognostic Factors, Clinical Outcomes" Biomedicines 12, no. 4: 901.
https://doi.org/10.3390/biomedicines12040901
APA Style
Gupta, M., Anjari, M., Brandner, S., Fersht, N., Wilson, E., Thust, S., & Kosmin, M.
(2024). Isocitrate Dehydrogenase 1/2 Wildtype Adult Astrocytoma with WHO Grade 2/3 Histological Features: Molecular Re-Classification, Prognostic Factors, Clinical Outcomes. Biomedicines, 12(4), 901.
https://doi.org/10.3390/biomedicines12040901
